Skip to content

CRYO-CELL INTERNATIONAL, INC.: 10-Q filed 2015-04-14

What CRYO-CELL INTERNATIONAL, INC. reported in its quarterly report filed 2015-04-14 (fiscal Q1 2015): 32 published measures, 66 facts as tagged in accession 0001193125-15-129576.

This filing

Form
10-Q (quarterly report)
Filed
2015-04-14
Fiscal period
fiscal Q1 2015
Accession
0001193125-15-129576 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CRYO-CELL INTERNATIONAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-02-2810,519,365USD
At 2014-11-3010,209,586USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-02-28-10,280,774USD
At 2014-11-30-10,726,663USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-02-283,550,243USD
At 2014-11-303,279,267USD
At 2014-02-283,243,003USD
At 2013-12-013,925,156USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-12-01 to 2015-02-28286,170USD90
2013-12-02 to 2014-02-28397,112USD89

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-12-01 to 2015-02-2823,303USD90
2013-12-02 to 2014-02-2811,025USD89

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-12-01 to 2015-02-284,843,381USD90
2013-12-02 to 2014-02-285,320,482USD89

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-02-28-33,289,164USD
At 2014-11-30-33,575,334USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-12-01 to 2015-02-289,824,566shares90
2013-12-02 to 2014-02-2810,690,188shares89

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-12-01 to 2015-02-2810,058,649shares90
2013-12-02 to 2014-02-2810,764,158shares89

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-12-01 to 2015-02-280.03USD/shares90
2013-12-02 to 2014-02-280.04USD/shares89

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-12-01 to 2015-02-280.03USD/shares90
2013-12-02 to 2014-02-280.04USD/shares89

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-12-01 to 2015-02-2825,412USD90
2013-12-02 to 2014-02-2847,291USD89

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-02-28918,190USD
At 2014-11-30953,415USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-12-01 to 2015-02-28190,513USD90
2013-12-02 to 2014-02-28152,236USD89

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-12-01 to 2015-02-28625,191USD90
2013-12-02 to 2014-02-28804,525USD89

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-02-288,847,004USD
At 2014-11-308,491,959USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-12-01 to 2015-02-28301,286USD90
2013-12-02 to 2014-02-28274,316USD89

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-02-288,702,930USD
At 2014-11-309,127,161USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-02-281,335,709USD
At 2014-11-30992,910USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2015-02-284,200,003USD
At 2014-11-304,071,997USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2014-12-01 to 2015-02-2839,042USD90
2013-12-02 to 2014-02-28451,913USD89

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2014-12-01 to 2015-02-282,913,973USD90
2013-12-02 to 2014-02-283,122,723USD89

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-12-01 to 2015-02-2811,988USD90
2013-12-02 to 2014-02-2814,368USD89

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-02-289,993,808shares
At 2014-11-309,706,174shares

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2015-02-28754,171USD
At 2014-11-30764,212USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2015-02-2812,097,209USD
At 2014-11-3011,809,088USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2015-02-28907,075USD
At 2014-11-301,471,699USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-12-01 to 2015-02-28311,582USD90
2013-12-02 to 2014-02-28444,403USD89

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-12-01 to 2015-02-28-4,075USD90
2013-12-02 to 2014-02-2827,769USD89

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-12-01 to 2015-02-28-305,361USD90
2013-12-02 to 2014-02-28-246,547USD89

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-12-01 to 2015-02-28268,511USD90
2013-12-02 to 2014-02-28529,649USD89

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-12-01 to 2015-02-28342,799USD90
2013-12-02 to 2014-02-28231,176USD89

Inspect the source

Entity
CRYO-CELL INTERNATIONAL, INC. / CIK 0000862692
Captured
2026-09-20T04:59:44.726Z
SEC response SHA-256
db6274ac13e8b9460d5d6692afefc40788c565b8fd343e40b722f12a7b8f95ac

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000862692.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))